MediPharm Labs Corp. (LABS.TO)
CAD 0.06
(-7.69%)
CAD 0.06
(-7.69%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.47 Million CAD | 35.72% |
| 2022 | -27.08 Million CAD | 31.52% |
| 2021 | -38.54 Million CAD | 38.03% |
| 2020 | -53.4 Million CAD | -702.19% |
| 2019 | 9.98 Million CAD | 240.31% |
| 2018 | -6.99 Million CAD | -16792.86% |
| 2017 | -42 Thousand CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.63 Million CAD | 39.43% |
| 2024 Q1 | -3.05 Million CAD | -12.02% |
| 2023 FY | - CAD | 35.72% |
| 2023 Q4 | -2.63 Million CAD | 26.04% |
| 2023 Q3 | -3.56 Million CAD | 47.18% |
| 2023 Q2 | -6.74 Million CAD | -160.24% |
| 2023 Q1 | -2.59 Million CAD | 24.11% |
| 2022 Q1 | -6.63 Million CAD | 51.9% |
| 2022 FY | - CAD | 31.52% |
| 2022 Q4 | -3.41 Million CAD | 52.28% |
| 2022 Q3 | -7.16 Million CAD | 12.96% |
| 2022 Q2 | -8.22 Million CAD | -23.94% |
| 2021 FY | - CAD | 38.03% |
| 2021 Q4 | -13.79 Million CAD | -111.95% |
| 2021 Q3 | -6.51 Million CAD | 33.98% |
| 2021 Q2 | -9.86 Million CAD | -41.23% |
| 2021 Q1 | -6.98 Million CAD | 66.11% |
| 2020 Q3 | -15.38 Million CAD | -367.8% |
| 2020 Q2 | -3.28 Million CAD | 84.09% |
| 2020 Q1 | -20.67 Million CAD | -1267.26% |
| 2020 FY | - CAD | -702.19% |
| 2020 Q4 | -20.6 Million CAD | -33.9% |
| 2019 FY | - CAD | 240.31% |
| 2019 Q3 | 6.12 Million CAD | 24.55% |
| 2019 Q2 | 4.92 Million CAD | 1082.93% |
| 2019 Q1 | 416 Thousand CAD | -70.62% |
| 2019 Q4 | -1.51 Million CAD | -124.67% |
| 2018 Q4 | 1.41 Million CAD | 1451.24% |
| 2018 Q2 | -11.94 Thousand CAD | 94.26% |
| 2018 Q1 | -208.27 Thousand CAD | -849.45% |
| 2018 FY | - CAD | -16792.86% |
| 2018 Q3 | -104.79 Thousand CAD | -777.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q4 | -21.93 Thousand CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 151.177% |
| Avicanna Inc. | -7.35 Million CAD | -42.452% |
| Avant Brands Inc. | 4.83 Million CAD | 316.667% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 62.417% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 23384.444% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 125.62% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 94.953% |
| Canopy Growth Corporation | -312.82 Million CAD | 96.651% |
| Willow Biosciences Inc. | -11.06 Million CAD | 5.271% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | 3.206% |